Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Gbathat

PMN

RE:RE:RE:Oppenheimer 33rd Annual Conference on Monday, March 13

she may be reading off a script... one of the drawbacks for the webinar world

March 14, 2023

PMN

RE:RE:Oppenheimer 33rd Annual Conference on Monday, March 13

I think she sounds find.  But I am a nerd.

March 14, 2023

ABOS

RE:RE:Great company with great working capital

agreed, it is a lot of cash on hand.   I think ABOS is perhaps a...

March 2, 2023

PMN

RE:Gbathat the second Boston Group mole is surfacing!!

$5 share price is what is needed to stay listed on Nasdaq.  So yes, the...

February 27, 2023

PMN

RE:RE:Acumen PR Feb 13/23

Acumen has cash holdings of over $180M. I'm not convinced that Acumen...

February 25, 2023

V.KALO

RE:Anyone else see this update?

https://www.sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo...

February 24, 2023

PMN

RE:RE:bball67 the Boston Group mole has surfaced ??

I think our current valuation is generally consistent with ABOS.  ABOS...

February 23, 2023

PMN

RE:RE:ut oh for ABOS

Also, I'm not sure I agree with the Twitter post in interpreting the...

February 7, 2023

PMN

RE:RE:ut oh for ABOS

There is some information on plaque binding for ACU193 published in a review...

February 7, 2023

PMN

RE:ut oh for ABOS

I'm still trying to assess this situation for abos Phase I plan In June...

February 7, 2023

PMN

ut oh for ABOS

my twitter feed is telling me ABOS is having some ARIA E issues in Phase I......

February 2, 2023

PMN

corporate update looks great

lays out a great business case that is getting back on track... let's do...

February 2, 2023

V.KALO

kalo is on fire, the ring of fire

kalo is on fire, the ring of fire kalo is on fire, the ring of fire kalo is...

January 31, 2023

V.KALO

here we go

Kalo is cruising... loving the news

January 25, 2023

PMN

SAVA update

looks like yet another one bites the dust... it's up to PMN and ABOS in...

January 24, 2023

PMN

the crazy thing

Biogen and Elsai stocks moved violently upward on the order of $5-20B shortly...

January 23, 2023

V.KALO

market cap is still tiny relative to future opportunity

huge moves in Kalo share price and market cap this month but it is still a...

January 23, 2023

V.KALO

Insider ownership 23% as of Dec 2022

see investor presentation

January 23, 2023

V.KALO

insider buying

putting their money where their mouth is... gotta love it. go KALO!

January 17, 2023

PMN

RE:Whats the benchmark PMN needs to beat

let's see what 60 mg/kg of a more targeted antibody can do... go PMN...

January 7, 2023

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Theralase Technologies Inc.

Theralase Technologies Inc. V.TLT

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research ... view more »